COVID-19 vaccine: Govt issues company-wise supply plan of Remdesivir to states, UTs
The companies have been instructed to ensure timely supplies of Remdesivir to all states/UTs strictly as per the supply plan
BusinessToday.In | May 8, 2021 | Updated 15:08 IST
The development comes in continuation to the allocation of Remdesivir to states/UTs done on Friday, May 7
The Centre on Saturday, May 8, issued a company-wise supply plan of antiviral drug Remdesivir to states and Union Territories (UTs). Remdesivir is a key drug used in the treatment of COVID-19 patients. The company-wise supply plan of Remdesivir for the period April 21 to May 16 has been issued to states/UTs, read an official statement by the Ministry of Chemicals and Fertilizers.
To ensure smooth supply of remdesivir used in the treatment of COVID-19 across the country, the allocation of the antiviral drug to the states and union territories has been made up to May 16, Union Chemicals and Fertilisers Minister Sadananda Gowda said on Friday. The production capacity of remdesivir has been increased to 1.03 crore vials per month, up from 38 lakh vials per month earlier, the minister had said on Tuesday. Considering the requirement of Remdesivir in every state and ensuring its adequate availability, allocation of #Remdesivir has been made upto 16th May 2021. This will ensure smooth supply of Remdesivir across country so that no patient face difficulty in this #pandemic time, Gowda said in a tweet.
Allocation of remdesivir made up to May 16 to ensure adequate availability: Sadananda Gowda
The allotment is being made for the states/UTs and it is the state governments and UTs that have to monitor proper distribution.
Share Via Email
| A+A A- By PTI
NEW DELHI: To ensure smooth supply of remdesivir used in the treatment of COVID-19 across the country, the allocation of the antiviral drug to the states and union territories has been made up to May 16, Union Chemicals and Fertilisers Minister Sadananda Gowda said on Friday.
The production capacity of remdesivir has been increased to 1.03 crore vials per month, up from 38 lakh vials per month earlier, the minister had said on Tuesday.
16.5 lakh vials of Remdesivir allocated to states between May 3-May 9: Centre ANI | Updated: May 05, 2021 17:10 IST
New Delhi [India], May 5 (ANI): The Centre on Wednesday informed that 16.5 lakh vials of Remdesivir were allocated to states between May 3 and May 9 , in wake of the Covid-19 pandemic. Union Minister of Chemicals and Fertilisers, DV Sadananda Gowda chaired a meeting to review the availability of drugs for Covid treatment and other essential drugs , informed an official release by the Ministry of Chemicals and Fertilizers.
Gowda during the meeting appreciated the efforts of all seven manufacturers of Remdesivir for increasing the production capacity to 1.03 crore vials per month, up from 38 lakh vials per month a month ago. This increased capacity will augment the domestic availability of the injection.
16.5L vials of Remdesivir allocated to states from May 3-9: Govt
By IANS |
4 Views
Two male nurses held for selling Remdesivir. Image Source: IANS News
New Delhi, May 5 : Union Minister of Chemicals & Fertilisers, D.V. Sadananda Gowda, on Wednesday reviewed the availability of drugs for Covid treatment and other essential medicines.
Gowda said that 16.5 lakh vials of Remdesivir have been allocated to all the states between May 3 and May 9, adding that since April 21, a total allocation of 34.5 lakh vials has been made to the states.
Allocation to the states is a dynamic process and efforts will be made to further enhance supply in the coming weeks, he said.